carcinoma

(redirected from Bronchioloalveolar carcinoma)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

carcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

carcinoma

[‚kärs·ən′ō·mə]
(medicine)
A malignant epithelial tumor.

carcinoma

Pathol
1. any malignant tumour derived from epithelial tissue
2. another name for cancer
References in periodicals archive ?
Refactory hypoxemia due to intrapulmonary shunting associated with bronchioloalveolar carcinoma.
Bronchioloalveolar Carcinoma Mimicking Tuberculosis-A Case Report With Autopsy Findings.
The term mucinous bronchioloalveolar carcinoma is no longer used just as the term bronchioloalveolar carcinoma is no longer used.
But now, after decades of beneficial service, the term bronchioloalveolar carcinoma has itself fallen victim to our better understanding of lung cancer.
In their review, "The Demise of the Term Bronchiolo-alveolar Carcinoma" Drs Allen and Butt state, "The term bronchioloalveolar carcinoma serves as a good example of a utile, descriptive term that, over time, with increased understanding, ran its course and attained obsolescence.
Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
The classification further subdivides MA depending on the extent of lepidic versus invasive growth pattern into MA in situ, mucinous minimally invasive ACA, or invasive MA (formerly classified as mucinous bronchioloalveolar carcinoma according to the 2004 World Health Organization classification scheme).
Bronchioloalveolar carcinoma arising in a congenital pulmonary airway malformation in a child: case report with an update of this association.
Repeat CT scan after 3 months revealed growth of the lesion, and a transthoracic needle biopsy was performed, from which a diagnosis of nonmucinous adenocarcinoma in situ (AIS, formerly bronchioloalveolar carcinoma (2)) was made.
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
These relate to the discontinuation of the terms bronchioloalveolar carcinoma and adenocarcinoma, mixed subtype, as well as the introduction of micropapillary as a new histologic subtype, the term lepidic pattern for the former bronchioloalveolar carcinoma growth pattern, and the specific term invasive mucinous adenocarcinoma for overtly invasive tumors previously classified as mucinous bronchioloalveolar carcinoma.
For example, the term bronchioloalveolar carcinoma (BAC) was very confusing as it was used in several different ways in the revised classification (1) to encompass 5 different types of lung adenocarcinoma with dramatically different clinical and pathologic characteristics.

Full browser ?